Navigation Links
US Drug Watchdog Now Urges Women Who Had A Out Of The Blue Heart Attack Or Stroke Who Were Also Using Yaz or Yasmin Birth Control Pills To Call The Johnson Law Group ASAP
Date:1/17/2013

(PRWEB) January 17, 2013

The US Drug Watchdog says, “We are urging close friends, family members, or mothers of younger women who had an out the blue heart attack, a stroke, a pulmonary embolism, developed a blood clot or other severe medical complications to contact the Johnson Law Group immediately, if the victim was also using the birth control pills called Yaz, Yasmin, or generic version Ocella." As a background, in September of 2009, the US FDA released a warning letter sent to Bayer Pharmaceuticals over Yaz & Yasmin. The letter indicates that the drug maker hid out-of-specification test results for key ingredients in the birth control pills. The US Drug Watchdog says, "If you, a friend, or a loved one was using birth control pills called Yaz, Yasmin, or their generic version Ocella, and severe side effects occurred, such a pulmonary embolism, a heart attack, a stroke, or other severe medical conditions please contact The Johnson Law Group immediately at 1-800-996-9900. http://www.johnsonlawgroup.com/

Possible Side Effects Yaz/Yasmin Birth Control Pills

  • Yaz / Yasmin Stroke or Heart attack
  • Yaz / Yasmin Pulmonary Embolism
  • Yaz / Yasmin Deep Vein Thrombosis
  • Yaz / Yasmin Blood Clots
  • Sudden Death from Yaz or Yasmin

The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and suggesting possible help for victims. In the instances of the birth control pills called Yaz. Yasmin, or their generic version Ocella we doubt a young woman would ever
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Offers Victims Of A Transvaginal Mesh Product Failure The Names Of The Best Possible Women Lawyers To Help Natiowide
2. US Drug Watchdog Now Offers Metal on Metal Hip Implant Recipients With Elevated Metal Levels the Names of the Best Attorneys-Get Compensated
3. US Drug Watchdog Now Urges Loved Ones Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If The Loved One Also Used the Diabetes Drug Called Actos
4. US Drug Watchdog Now Urges Transvaginal Mesh Product Failure Victims To Call Them For The Names Of The Best Women Attorneys To Help Them With A Staggering Dilemma
5. US Drug Watchdog Now Offers To Help All DePuy Pinnacle All Metal Hip Implant Recipients get to the Best Law Firms If A Blood Test Reveals Elevated Metal Levels
6. US Drug Watchdog Now Urges Victims of a Transvaginal Mesh Product Failure To Get Some Meaningful Help From Women Attorneys Who Understand This Horrific Mess and the Costs
7. US Drug Watchdog Now Urges All 500,000 US Recipients Of A Metal on Metal Hip Implant To Get A Blood Test for Elevated Levels Of Cobalt and Chromium
8. US Drug Watchdog Now Urges Victims of a Unsuccessful Transvaginal Mesh Product Revision Surgery to Call Them for the Names of the Best Possible Lawyers - Who Are All Women
9. US Drug Watchdog Now Puts a New Emphasis on DePuy Pinnacle Hip Implant Recipients and They Urge Them to Get a Blood Test for Elevated Metals Levels
10. US Drug Watchdog Now Urges Families Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If They Used the Diabetes Drug Called Actos
11. US Drug Watchdog Is Now Open All Weekends To Help Victims Of A Transvaginal Mesh Product Failures With A Service That Includes Naming Top Attorneys--Who Are All Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2013)... 2013 The Wisconsin Board for People ... a new winner in its storytelling campaign, Better Together: ... ways ordinary people come together to support one another ... Laurie D., of Almond, WI, is recognized this month ... story. , In her story submission, Laurie ...
(Date:12/13/2013)... December 13, 2013 Every year, over ... slavery where they are abused, sexually assaulted and denied ... Award is taking a stand against traffickers to protect ... 100% of every donation received during the holidays supports ... Honorees, including Triveni Acharya, an Indian activist who has ...
(Date:12/13/2013)... WA (PRWEB) December 13, 2013 The ... Healthreviewcenter.com delivers 12 warning signs of dementia and 5 ... different aspects of Alzheimer’s and dementia disease. This article ... lower the chances of suffering dementia for their family ... supplements. In the first part of the article, people ...
(Date:12/13/2013)... 13 December 2013: Echocardiography with conventional M-mode ... effective way to increases the accuracy of pre-participation ... 2013 by Dr Alexander Kisko from Presov, Slovakia. ... of the European Association of Cardiovascular Imaging (EACVI), ... Cardiology (ESC). It takes place during 11-14 December ...
(Date:12/12/2013)... 2013 Risperdal lawsuits ( http://www.risperdallawsuitcenter.com/ ) ... drug caused some men and young boys to develop ... in a consolidated litigation underway in the Philadelphia Court ... filed earlier this month, Plaintiffs have asked the court ... allow some Risperdal clinical studies to remain sealed. ...
Breaking Medicine News(10 mins):Health News:Wisconsin BPDD Awards Tale of an "Extraordinary Life" 2Health News:World of Children Award Rescues Girls from Forced Prostitution With Holiday Donations 2Health News:A New “Ways To Prevent Dementia” Article Introduces to People Simple Tips to Prevent Alzheimer’s and Dementia Disease – Healthreviewcenter 2Health News:A New “Ways To Prevent Dementia” Article Introduces to People Simple Tips to Prevent Alzheimer’s and Dementia Disease – Healthreviewcenter 3Health News:New screening strategy to prevent cardiovascular complications in sports 2Health News:New screening strategy to prevent cardiovascular complications in sports 3Health News:Risperdal Lawsuits Progress, as Bernstein Liebhard LLP Notes Filing of Plaintiff Brief Seeking to Unseal Risperdal Clinical Studies 2Health News:Risperdal Lawsuits Progress, as Bernstein Liebhard LLP Notes Filing of Plaintiff Brief Seeking to Unseal Risperdal Clinical Studies 3
... 23 /PRNewswire-FirstCall/ -- InfoLogix, ... a leading technology provider of enterprise mobility solutions ... the company has entered into an agreement with ... healthcare network based in suburban Atlanta, to deploy ...
... plan more controlled study at different dosages , , THURSDAY, ... to determine whether grape seed extract lowers hormone levels ... say researchers at the City of Hope cancer center ... grape seed extract inhibits aromatase, an enzyme that helps ...
... white bread, other ,high-glycemic, carbs, researchers say , , THURSDAY, April ... in before a workout may influence how many calories you ... ate a breakfast rich in carbohydrates that do not cause ... skimmed milk -- burned 50 percent more fat during a ...
... Corporation, a leading Life Science and High Technology company, reported ... to $0.68 from $0.64 in the first quarter of 2008.Reported ... a decline of 9% from the first quarter of 2008. ... by 1% from a year ago. Organic sales for the ...
... April 23 Nurses with grave concerns about the care ... to address those fears directly to Heather Howard, New Jersey ... (Thursday April 23) beginning at about 11:30 a.m.Some 80 Registered ... Union of Hospital and Health Care Employees, have been without ...
... -- Genesis,Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ... operations in the People,s,Republic of China, today announced ... Inc." ("Jiangbo"). , The ... of the,State of Florida that the Certificate of ...
Cached Medicine News:Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 2Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 3Health News:No Verdict Yet on Grape Seed Extract vs. Breast Cancer 2Health News:A Pre-Workout Meal to Help You Burn Fat 2Health News:A Pre-Workout Meal to Help You Burn Fat 3Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 2Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 3Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 4Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 5Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 6Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 7Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 8Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 9Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 10Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 11Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 12Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 13Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 14Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 15Health News:Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name 2Health News:Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name 3
(Date:12/13/2013)... LYNBROOK, N.Y. , Dec. 13, 2013  BioSpecifics ... biopharmaceutical company developing first in class collagenase-based products ... and XIAPEX ® in the EU, today ... has dosed the first patient in its Phase ... the treatment of frozen shoulder syndrome (adhesive capsulitis). ...
(Date:12/13/2013)... , Dec.13, 2013 Celsion Corporation (NASDAQ: ... announced the presentation of the combined clinical study results ... Duke University sponsored Phase I trial of ThermoDox® plus ... (BCRCW) at the 2013 San Antonio Breast Cancer Conference ... between 7:30 am to 9:00 am (local time). The ...
(Date:12/13/2013)... Dec. 13, 2013 /PRNewswire-iReach/ -- Texas Children,s Heart Center is ... Cardiology, which is designed to medically manage the risk factors ... only one of its kind in Texas ... risk factors or who have a strong family history of ... of Kawasaki disease. For more information ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Initiation of Phase 2b Trial of CCH for Treatment of Frozen Shoulder Syndrome 2BioSpecifics Technologies Corp. Announces Initiation of Phase 2b Trial of CCH for Treatment of Frozen Shoulder Syndrome 3BioSpecifics Technologies Corp. Announces Initiation of Phase 2b Trial of CCH for Treatment of Frozen Shoulder Syndrome 4Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference 2Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference 3Texas Children's Center for Preventive Cardiology is the only center in Texas offering multidisciplinary, specialized care for children at risk for acquired heart disease 2Texas Children's Center for Preventive Cardiology is the only center in Texas offering multidisciplinary, specialized care for children at risk for acquired heart disease 3
...  Amgen (NASDAQ: AMGN ) today announced the final ... at 12:00 midnight, New York City time, on Wednesday, Dec. ... 83,333,333 shares of its common stock at a price of ... billion, excluding fees and expenses relating to the tender offer. ...
... Unity Management Group, Inc. (OTCMARKETS: UYMG) "UNITY" (or the "Company"), ... announce that it has sold its initial PZ Uno Tablet ... confidentiality agreements the company is not able to disclose the ... PZ Uno tablet press would be used for a research ...
Cached Medicine Technology:Amgen Announces Final Results of Its Tender Offer 2Amgen Announces Final Results of Its Tender Offer 3Unity Management Group, Inc. Announces Its Initial Sale of the PZ UNO Tablet Press to a Major Pharmaceutical Company for $500,000 2
Delicate # 4...
Curved shafts with fine pointed tips. Smooth handle with dull finish....
Straight tips with delicate serrations. Serrated handle with polished finish....
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish....
Medicine Products: